Key facts
- This page summarizes Christopher Twitty's Form 3 filing for Skye Bioscience, Inc. (SKYE).
- 0 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 25 Apr 2025, 16:03.
Christopher Twitty - 23 Apr 2025 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- SKYE
- Reported as of
- 23 Apr 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 25 Apr 2025, 16:03:41 UTC
- Prior SEC filing
- 10 Mar 2022
- Next SEC filing
- 09 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kaitlyn Arsenault, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher Twitty filed Form 3 for Skye Bioscience, Inc. (SKYE) on 25 Apr 2025.
Change
- Previous filing in this sequence was filed on 10 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SKYE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 81,242
- Date
- 23 Apr 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SKYE
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 23 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,004
- Exercise price
- $3.50
- Footnotes
- F2
SKYE
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 23 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $14.56
- Footnotes
- F3
SKYE
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 23 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,100
- Exercise price
- $3.50
- Footnotes
- F4
SKYE
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 23 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 200,000
- Exercise price
- $5.15
- Footnotes
- F5
SKYE
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 23 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 150,000
- Exercise price
- $2.89
- Footnotes
- F6
SKYE
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 23 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,000
- Exercise price
- $4.25
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Includes (a) 14,060 restricted stock unit ("RSU") awards that vests upon the company achieving a market capitalization of $500 million or more and (b) 25,000 RSUs that vest upon the achievement of the following performance milestones: (i) 25% vests upon the company achieving a market capitalization of $750 million and a stock price of $20.00 per share, (ii) an additional 25% vests upon the company achieving a market capitalization of $1 billion and a stock price of $25.00 per share, (iii) an additional 25% vests upon the company achieving a market capitalization of $1.25 billion and a stock price of $30.00 per share and (iv) an additional 25% vests if the company achieves a market capitalization of $1.5 billion or greater and a stock price of $35.00 per share.
Footnote F2
The stock option vests in equal monthly installments over the four year period beginning on August 24, 2023.
Footnote F3
The stock option vests in equal monthly installments over the four year period beginning February 29, 2024.
Footnote F4
The stock option vests in equal monthly installments over the four year period beginning August 24, 2023.
Footnote F5
The stock option vests in equal monthly installments over the four year period beginning October 28, 2024.
Footnote F6
The stock option vests in equal monthly installments over the one year period beginning February 21, 2025.
Footnote F7
The stock option vests 25% on December 8, 2023 and 1/48th monthly thereafter.
SEC remarks
Exhibit List: Exhibit 24 - Power of Attorney